Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ansgar Weltermann

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Journal of Cancer Research and Clinical Oncology|March 6, 2023
TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancerIrene Strassl, Armin Windhager, Sigrid Machherndl-Spandl, et al.
Journal of Vascular Surgery|January 19, 2008
Genetic variation in heme oxygenase 1 (HMOX1) and the risk of recurrent venous thromboembolismStefan Mustafa, Ansgar Weltermann, Robert Fritsche, et al.
Archives of Internal Medicine|January 14, 2004
Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolismSabine Eichinger, Ansgar Weltermann, Erich Minar, et al.
Haematologica|November 11, 2003
Circulating hematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasiaVerena Sagaster, Eva Jäger, Ansgar Weltermann, et al.
Leukemia & Lymphoma|May 13, 2022
Efficacy and safety of voriconazole as invasive fungal infection prophylaxis in patients with acute myeloid leukemiaSigrid Machherndl-Spandl, Thomas Vockenhuber, Michaela Binder, et al.
European Journal of Haematology|August 22, 2003
Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myelomaHannes Kaufmann, Elisabeth Krömer, Thomas Nösslinger, et al.
Thrombosis and Haemostasis|January 4, 2007
Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancerGregor Hron, Marietta Kollars, Heinz Weber, et al.
Thrombosis Research|March 12, 2004
Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stentingAnsgar Weltermann, Peter Fritsch, Paul A Kyrle, et al.
Thrombosis and Haemostasis|April 30, 2003
The effect of beta-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolismVerena Schönauer, Sandra Giannini, Günter Christ, et al.
Thrombosis Research|November 30, 2004
Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosisSophie Ziegler, Wolfgang R Sperr, Paul Knöbl, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Journal of Cancer Research and Clinical Oncology|March 6, 2023
TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancerIrene Strassl, Armin Windhager, Sigrid Machherndl-Spandl, et al.
Journal of Vascular Surgery|January 19, 2008
Genetic variation in heme oxygenase 1 (HMOX1) and the risk of recurrent venous thromboembolismStefan Mustafa, Ansgar Weltermann, Robert Fritsche, et al.
Archives of Internal Medicine|January 14, 2004
Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolismSabine Eichinger, Ansgar Weltermann, Erich Minar, et al.
Haematologica|November 11, 2003
Circulating hematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasiaVerena Sagaster, Eva Jäger, Ansgar Weltermann, et al.
Leukemia & Lymphoma|May 13, 2022
Efficacy and safety of voriconazole as invasive fungal infection prophylaxis in patients with acute myeloid leukemiaSigrid Machherndl-Spandl, Thomas Vockenhuber, Michaela Binder, et al.
European Journal of Haematology|August 22, 2003
Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myelomaHannes Kaufmann, Elisabeth Krömer, Thomas Nösslinger, et al.
Thrombosis and Haemostasis|January 4, 2007
Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancerGregor Hron, Marietta Kollars, Heinz Weber, et al.
Thrombosis Research|March 12, 2004
Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stentingAnsgar Weltermann, Peter Fritsch, Paul A Kyrle, et al.
Thrombosis and Haemostasis|April 30, 2003
The effect of beta-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolismVerena Schönauer, Sandra Giannini, Günter Christ, et al.
Thrombosis Research|November 30, 2004
Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosisSophie Ziegler, Wolfgang R Sperr, Paul Knöbl, et al.
Pageof 6